Introduction

The Journal of Clinical Intensive Care and Medicine (JCICM) maintains transparent and rigorous editorial policies designed to uphold the highest academic, ethical, and professional publishing standards. Our policies align with global best practices, including guidelines from the Committee on Publication Ethics (COPE), the International Committee of Medical Journal Editors (ICMJE), and the World Association of Medical Editors (WAME).

Editorial Independence

Editorial decisions are made independently by the editorial board without influence from publishers, sponsors, or external stakeholders. The Editor-in-Chief and associate editors are responsible for ensuring fairness, impartiality, and scientific rigor in all publication decisions. Conflicts of interest are disclosed and managed to safeguard transparency.

Peer Review Policy

JCICM follows a double-blind peer review process where both authors and reviewers remain anonymous. Reviewers are selected based on expertise, impartiality, and absence of conflicts of interest. The average peer review timeline is 3–4 weeks, with revisions evaluated promptly to ensure timely publication.

Confidentiality

Manuscripts submitted to JCICM are treated with strict confidentiality. Editors and reviewers are prohibited from disclosing or using any part of an unpublished manuscript for personal or professional advantage. Reviewer identities are protected unless disclosure is requested by both author and reviewer.

Conflict of Interest

Authors, reviewers, and editors must declare all potential conflicts of interest. These may include financial relationships, professional affiliations, or personal beliefs that could influence objectivity. Declarations are published alongside accepted articles to maintain transparency.

Corrections, Retractions, and Expressions of Concern

JCICM is committed to maintaining the integrity of the scholarly record. Errors in published articles are corrected promptly. Serious ethical breaches or invalid findings may lead to retraction, accompanied by a formal notice. Expressions of concern are issued if investigations are pending.

Data Sharing and Transparency

Authors are encouraged to make underlying data available for verification and reproducibility. JCICM supports FAIR data principles (Findable, Accessible, Interoperable, Reusable) and encourages deposit in recognized repositories. Clinical trial data must follow CONSORT reporting standards.

Ethics in Human and Animal Research

Research involving human subjects must comply with the Declaration of Helsinki, and studies involving animals must follow internationally recognized ethical standards. Authors must provide details of ethical approval and informed consent within their manuscripts.

Author Responsibilities

  • Ensure originality and proper attribution of all work submitted.
  • Disclose funding sources, conflicts of interest, and ethical approvals.
  • Follow manuscript preparation guidelines strictly to facilitate peer review.

Reviewer Responsibilities

  • Provide constructive, unbiased, and timely feedback on assigned manuscripts.
  • Maintain confidentiality and avoid conflicts of interest.
  • Alert editors to potential ethical issues such as plagiarism or duplicate publication.

Editorial Board Responsibilities

The editorial board ensures adherence to policies, selects qualified reviewers, and provides strategic direction to enhance the journal’s scientific impact and ethical standards.

FAQs

What if I discover an error after publication? Authors should immediately contact the editorial office to issue a correction.

Are reviewer comments shared with other reviewers? No, unless anonymized comments are used for transparency and training.

Can rejected articles be resubmitted? Yes, if substantially revised and accompanied by a detailed response letter.